|
PPM1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6269208202857E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.1936454309166E-12 |
| Normal-vs-Stage2 |
1.51029999617691E-08 |
| Normal-vs-Stage3 |
5.15143483426073E-14 |
| Normal-vs-Stage4 |
1.78523862359725E-12 |
| Stage1-vs-Stage2 |
5.278600E-01 |
| Stage1-vs-Stage3 |
7.911900E-02 |
| Stage1-vs-Stage4 |
1.358010E-02 |
| Stage2-vs-Stage3 |
5.469000E-01 |
| Stage2-vs-Stage4 |
1.501240E-01 |
| Stage3-vs-Stage4 |
2.618200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.66293670342566E-15 |
| Normal-vs-AfricanAmerican |
7.80730000000673E-05 |
| Normal-vs-Asian |
8.27479995635372E-09 |
| Caucasian-vs-AfricanAmerican |
3.893800E-01 |
| Caucasian-vs-Asian |
8.784000E-01 |
| AfricanAmerican-vs-Asian |
4.310600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25122134875255E-12 |
| Normal-vs-Female |
1.64424029946986E-12 |
| Male-vs-Female |
7.246400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.31960056402181E-11 |
| Normal-vs-Age(41-60Yrs) |
1.6064927166326E-13 |
| Normal-vs-Age(61-80Yrs) |
1.63469238145808E-12 |
| Normal-vs-Age(81-100Yrs) |
2.923900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.901430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.978270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.824400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.158600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.602600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.500000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.623440E-04 |
| Classical-VS-Follicular |
4.357700E-03 |
| Classical-VS-Other |
3.285800E-01 |
| Classical-VS-Normal |
3.21429549643426E-11 |
| Tall-VS-Follicular |
1.730200E-01 |
| Tall-VS-Other |
4.902800E-01 |
| Tall-VS-Normal |
4.65072425015478E-13 |
| Follicular-VS-Other |
9.801200E-01 |
| Follicular-VS-Normal |
2.29094521131401E-12 |
| Other-VS-Normal |
8.047000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.66293670342566E-15 |
| Normal-vs-N1 |
3.05120373411683E-11 |
| N0-vs-N1 |
4.968400E-01 |
|
|
